Oral delivery of biologics using drug-device combinations
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 36, 8-13
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
- National Institutes of Health (EB-000244)
This publication has 50 references indexed in Scilit:
- Simulation of peristaltic flow of chyme in small intestine for couple stress fluidMeccanica, 2013
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Capsule Retentions and Incomplete Capsule Endoscopy Examinations: An Analysis of 2300 ExaminationsGastroenterology Research and Practice, 2011
- Development of enteric submicron particle formulation of papain for oral deliveryInternational Journal of Nanomedicine, 2011
- Modeling the Fluid Dynamics in a Human Stomach to Gain Insight of Food DigestionJournal of Food Science, 2010
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trialThe Lancet, 2010
- Experience With a Pill-Swallowing Enhancement AidClinical Pediatrics, 2010
- Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrierProceedings of the National Academy of Sciences, 2009
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)The Lancet, 2009
- Gastrointestinal Safety of an Extended-Release, Nondeformable, Oral Dosage Form (OROS??)*Drug Safety, 2002